Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)
The summary for the Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24): -Purpose. This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes on Health, encourages Research Project Grant (R24) applications from institutions that historically and/or currently serve students from diverse and disadvantaged backgrounds that aim to increase their capacity to conduct drug abuse and addiction research. The applications should propose to foster the research career development of a diverse cadre of faculty, students and staff who are currently underrepresented in drug abuse research, and to enhance research infrastructure at the institution.-Mechanism of Support. This FOA utilizes the R24 mechanism. -Funds Available and Anticipated Number of Awards. Funding is available in the amount of up to $350,000 per year in direct costs. The number of awards supported will depend on the number and scientific merit of the proposals received.
|Federal Grant Title:||Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Health Education|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PAR-09-011|
|Type of Funding:||Grant|
|CFDA Descriptions:||Drug Abuse and Addiction Research Programs|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Jul 15, 2011|
|Posted Date:||Oct 21, 2008|
|Creation Date:||Dec 03, 2008|
|Archive Date:||Dec 04, 2008|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification) Private institutions of higher education Public and State controlled institutions of higher education
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) .
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- Similar Government Grants
- • Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, An...
- • Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)
- • Research Networks for the Study of Recovery Support Services for Persons Treated with Medi...
- • The Rat Opioid Genome Project: Clinical Trials not Allowed (U01- Clinical Trial Not Allowe...
- • The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)
- • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
- • Drug Abuse Aspects of Hiv/Aids and Other Infections
- • Epidemiology of Drug Abuse
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...